| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/20/1997 | CA2232262A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
| 03/20/1997 | CA2232140A1 Cyclic hexapeptide compound |
| 03/20/1997 | CA2232089A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | CA2232048A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | CA2232033A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | CA2232002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | CA2231998A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | CA2231804A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | CA2231769A1 Composition and method for treating diseased nails |
| 03/20/1997 | CA2231685A1 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/20/1997 | CA2231220A1 Peptide derivatives |
| 03/20/1997 | CA2231174A1 Peptide derivatives |
| 03/20/1997 | CA2231043A1 Method for analyzing isomers of enalapril and enalaprilat |
| 03/20/1997 | CA2229307A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 03/20/1997 | CA2205056A1 Method for reducing the severity of gastro-intestinal damage |
| 03/19/1997 | EP0763598A1 Method of preparing a fusion protein |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763596A1 Process for producing thrombin |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763537A2 Non-peptidyl Ras farnesyl transferase inhibitors |
| 03/19/1997 | EP0763360A1 Hepatopathy remedy |
| 03/19/1997 | EP0763358A1 Buccal delivery system for therapeutic agents |
| 03/19/1997 | EP0763202A1 Encoded combinatorial libraries |
| 03/19/1997 | EP0763123A1 Safe retroviral vectors, their production and use |
| 03/19/1997 | EP0763122A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 03/19/1997 | EP0763121A1 Method of cancer treatment by p53 protein control |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 03/19/1997 | EP0763114A2 Hepatitis g virus and molecular cloning thereof |
| 03/19/1997 | EP0763111A1 Epil/placentine |
| 03/19/1997 | EP0763107A1 Pantropic neurotrophic factors |
| 03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763062A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
| 03/19/1997 | EP0763061A1 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments |
| 03/19/1997 | EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 03/19/1997 | EP0763055A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 03/19/1997 | EP0763052A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 03/19/1997 | EP0763051A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 03/19/1997 | EP0763046A1 Dna encoding gls1 |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0763009A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 03/19/1997 | EP0762890A1 Treatment of diabetes |
| 03/19/1997 | EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 03/19/1997 | EP0762888A1 Copolymer-1 improvements in compositions of copolymers |
| 03/19/1997 | EP0762887A1 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 03/19/1997 | EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
| 03/19/1997 | EP0762884A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 03/19/1997 | EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis |
| 03/19/1997 | EP0762880A1 Retroviral protease inhibitor combinations |
| 03/19/1997 | EP0762870A1 Virosome-mediated intracellular delivery of therapeutic agents |
| 03/19/1997 | EP0754302A4 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 03/19/1997 | EP0659191A4 Cloning and expression of pur protein. |
| 03/19/1997 | EP0659084B1 Medical preparations containing n-methylated cyclic undecapeptides |
| 03/19/1997 | EP0626861B1 Treatment for asthma |
| 03/19/1997 | EP0596881B1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
| 03/19/1997 | EP0566641B1 Use of human igf-i |
| 03/19/1997 | EP0561965A4 Enhancement of musculature in animals |
| 03/19/1997 | CN1145641A DNA mutagenesis by random fragmentation and reassembly |
| 03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
| 03/19/1997 | CN1145405A Tech. for brewing beer containing SOD |
| 03/19/1997 | CN1145404A Tech. for brewing beer containing SOD, hedgehogt polysaccharide and theaflavin |
| 03/19/1997 | CN1145365A Camptothecin derivatives |
| 03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
| 03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes |
| 03/18/1997 | US5612470 Nucleic acid encoding the growth hormone releasing hormone receptor |
| 03/18/1997 | US5612469 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 03/18/1997 | US5612460 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 03/18/1997 | US5612456 Factor XIII compositions |
| 03/18/1997 | US5612453 Viricides |
| 03/18/1997 | US5612369 Treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases |
| 03/18/1997 | US5612360 Aromatic n-heterocyclic compounds as hypotensive agents with acid groups, sulfonylcarboxamides or tetrazole groups |
| 03/18/1997 | US5612332 Inhibiting protein glycosylation |
| 03/18/1997 | US5612315 Pharmaceutical growth hormone formulations |
| 03/18/1997 | US5612314 Nitrosylated neuropeptides |
| 03/18/1997 | US5612313 Controlled-pH formulation for intravesicular instillation of TGFαPE40 ab |
| 03/18/1997 | US5612312 (igf-i)insulin-like growth factor i |
| 03/18/1997 | US5612311 Cyclic peptides |
| 03/18/1997 | US5612310 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 03/18/1997 | US5612216 Nucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereof |
| 03/18/1997 | US5612215 Stromelysin targeted ribozymes |
| 03/18/1997 | US5612212 Selective inhibition of cell proliferation by vav antisense oligonucleotides |
| 03/18/1997 | US5612211 Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
| 03/18/1997 | US5612209 Allergies |
| 03/18/1997 | US5612201 Genetic engineering and kits for determination of gene expression |
| 03/18/1997 | US5612196 Introducing exogenous dna code human serum albumin and culture in medium of ethanol, glycerol, sorbitol, sucrose or esters and recovering |
| 03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine |
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/18/1997 | US5612060 Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy |
| 03/18/1997 | US5612051 Method of treating involuntary muscle dysfunction with relaxin hormone |
| 03/18/1997 | US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers |
| 03/18/1997 | US5612034 Super-globuling for in vivo extended lifetimes |
| 03/18/1997 | US5612033 Methods of treatment using heat-treated IGM antibody preparations |